Simplex Trading, LLC Unity Biotechnology, Inc. Transaction History

Simplex Trading, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$0.4 - $4.27 $8,089 - $86,356	20,224 Added 207.43%	29,974 $11,000
Q2 2022 Aug 03, 2022	SELL	$0.56 - $1.29 $5,575 - $12,843	-9,956 Reduced 50.52%	9,750 $5,000
Q1 2022 May 02, 2022	SELL	$0.72 - $1.86 $51,580 - $133,248	-71,639 Reduced 78.43%	19,706 $22,000
Q4 2021 Feb 23, 2022	BUY	$1.3 - $3.17 $118,748 - $289,563	91,345 New	91,345 $133,000
Q1 2021 Apr 26, 2021	SELL	$5.51 - $9.42 $15,350 - $26,244	-2,786 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$3.42 - $6.36 $9,528 - $17,718	2,786 New	2,786 $0
Q2 2020 Jul 13, 2020	SELL	$5.28 - $9.67 $955 - $1,750	-181 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$5.0 - $7.6 $280 - $425	-56 Reduced 23.63%	181 $1,000
Q4 2019 Feb 05, 2020	BUY	$5.99 - $8.38 $1,419 - $1,986	237 New	237 $1,000
Q2 2019 Jul 26, 2019	SELL	$7.59 - $10.21 $842 - $1,133	-111 Closed	0 $0
Q1 2019 Apr 18, 2019	BUY	$7.65 - $16.66 $849 - $1,849	111 New	111 $0

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $14M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.